Cargando…
Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma
Suppressor of cytokine signaling 1 (SOCS1) mutations are among the most frequent somatic mutations in classical Hodgkin lymphoma (cHL), yet their prognostic relevance in cHL is unexplored. Here, we performed laser-capture microdissection of Hodgkin/Reed-Sternberg (HRS) cells from tumor samples in a...
Autores principales: | Lennerz, Jochen K., Hoffmann, Karl, Bubolz, Anna-Maria, Lessel, Davor, Welke, Claudia, Rüther, Nele, Viardot, Andreas, Möller, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745714/ https://www.ncbi.nlm.nih.gov/pubmed/26336985 |
Ejemplares similares
-
Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
por: Allen, Pamela B, et al.
Publicado: (2017) -
Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
por: Martynchyk, Arina, et al.
Publicado: (2023) -
Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018) -
Usefulness of BATF3 Immunohistochemistry in Diagnosing Classical Hodgkin Lymphoma
por: Benckendorff, Julian, et al.
Publicado: (2021) -
Composite follicular lymphoma and classic Hodgkin lymphoma
por: Kim, Han-Na, et al.
Publicado: (2022)